Docgo Inc. (DCGO) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Docgo Inc. (DCGO) stock forecast summary
Our AI ranks Docgo Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Docgo Inc. is a small-cap company with a market capitalization of $30M. It ranks number 10 by market capitalization among the 10 Services-Health Services issuers in our coverage with a current forecast. Its P/B Ratio of 0.25x is the lowest of the 9 peers that report one.
A per-ticker accuracy statistic for DCGO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, DCGO included.
Follow DCGO freeDCGO price chart and AI forecast
How DCGO ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Docgo Inc. (DCGO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Health Services peers listed below that report each metric.
Valuation & Market
| Metric | DCGO | Rank |
|---|---|---|
| Market Cap | $30M | 10/10 |
| P/B Ratio | 0.25x | 9/9 |
| EPS | $-1.89 | – |
| Book Value/Share | $1.20 | – |
| Revenue/Share | $2.98 | – |
| FCF/Share | $-0.26 | – |
Profitability & Margins
| Metric | DCGO | Rank |
|---|---|---|
| ROE | -161.6% | 9/10 |
| ROA | -103.0% | 9/10 |
| ROIC | -160.0% | 11/11 |
| Operating Margin | -62.2% | 10/12 |
| Net Margin | -65.3% | 8/10 |
| EBT Margin | -64.3% | 10/12 |
| Tax Rate | -9.1% | – |
Financial Health
| Metric | DCGO | Rank |
|---|---|---|
| Current Ratio | 1.66x | 5/11 |
| D/E Ratio | 0.76x | 7/12 |
| Financial Leverage | 1.57x | 8/12 |
| Interest Coverage | -365.2x | 11/11 |
| Working Capital | $47M | 6/11 |
Cash Flow
| Metric | DCGO | Rank |
|---|---|---|
| Operating Cash Flow | -$23M | 10/13 |
| Free Cash Flow | -$26M | 7/9 |
| Capital Spending | -$3M | 3/9 |
| OCF Growth YoY | -126.0% | 6/8 |
| FCF Growth YoY | -131.0% | 5/6 |
| FCF/Sales | -8.8% | 6/9 |
| CapEx/Sales | 1.1% | 7/9 |
Operational Efficiency
| Metric | DCGO | Rank |
|---|---|---|
| Asset Turnover | 1.58x | 3/11 |
| Receivables Turnover | 3.4x | 9/9 |
| Fixed Assets Turnover | 23.2x | 4/10 |
| Days Sales Outstanding | 107 days | 1/9 |
| Payables Period | -28 days | – |
Income Statement
| Metric | DCGO | Rank |
|---|---|---|
| Total Revenue | $294M | 9/11 |
| Operating Income | -$183M | 13/13 |
| Net Income | -$192M | 11/11 |
| R&D Expense | $14M | – |
| SG&A Expense | $157M | 6/11 |
| Cost of Goods Sold | -$184M | 8/8 |
Dividend & Shareholder Information
| Metric | DCGO | Rank |
|---|---|---|
| Shares Outstanding | 99M | – |
| EPS Growth | -619.5% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $120M | 64.1% of assets |
| Cash & Short-term Investments | $25M | 13.5% of assets |
| Accounts Receivable | $86M | 46.2% of assets |
| Total Liabilities | $91M | 48.7% of assets |
| Short-term Debt | $58M | 31.2% of assets |
DCGO quarterly financials and insider trading
Docgo Inc. (DCGO) industry peers
Companies classified under the same SEC industry code as Docgo Inc. (Services-Health Services): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| DCGO Docgo Inc. | ▲ | $30M |
| LFST Lifestance Health Group, Inc. | ▲ | $4.71B |
| PRVA Privia Health Group, Inc. | ▼ | $2.77B |
| WGS Genedx Holdings Corp. | ▲ | $1.94B |
| PNTG Pennant Group, Inc. | ▶ | $1.40B |
| USPH U S Physical Therapy Inc /Nv | ▶ | $1.27B |
| INNV Innovage Holding Corp. | ▲ | $1.23B |
| OMDA Omada Health, Inc. | ▲ | $1.12B |
| SRTA Strata Critical Medical, Inc. | ▲ | $394M |
| EUDA Euda Health Holdings Ltd | ▶ | $32M |
| ATPC Agape Atp Corp | ▼ | N/A |
| PIII P3 Health Partners Inc. | ▲ | N/A |
| VSEE Vsee Health, Inc. | ▼ | N/A |
Where DCGO sits on the market map
Docgo Inc. (DCGO) stock news
Loading...
Docgo Inc. (DCGO) stock forecast FAQ
What is the Docgo Inc. (DCGO) stock forecast?
Our AI ranks Docgo Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Docgo Inc. stock predictions?
A per-ticker accuracy statistic for DCGO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Docgo Inc. forecasts updated?
Docgo Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Docgo Inc.'s industry peers?
13 issuers in our coverage, DCGO included, share the SEC industry code Services-Health Services. The largest are: Lifestance Health Group, Inc. (LFST), Privia Health Group, Inc. (PRVA), Genedx Holdings Corp. (WGS), Pennant Group, Inc. (PNTG), U S Physical Therapy Inc /Nv (USPH), Innovage Holding Corp. (INNV).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.